5 research outputs found
Donor-Derived Cell-Free DNA in D-OAR, a Real World, Clinical Use Heart Transplant Population
No full textDoes simultaneous lung–liver transplantation provide an immunologic advantage compared with isolated lung transplantation?
No full textUtilization of hepatitis C virus\u2013infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement
No full textThe advent of therapies for successful treatment of hepatitis C virus has allowed the heart and lung transplant community to re-explore the use of hepatitis C virus\u2013positive donors for organ transplantation, with a benefit for many terminally ill patients. The consensus statements provided herein represent the current state of knowledge and expertise in this area, which we expect will continue to rapidly evolve over the next few years
